HR
ABBV icon

Hardy Reed’s AbbVie ABBV Stock Holding History

Hardy Reed’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42M Sell
9,616
-296
-3% -$63.7K 0.16% 61
2026
Q1 		$2.16M Sell
9,912
-475
-5% -$105K 0.16% 59
2025
Q4 		$2.37M Buy
10,387
+126
+1% +$28.7K 0.17% 55
2025
Q3 		$2.38M Buy
10,261
+415
+4% +$84.5K 0.17% 50
2025
Q2 		$1.83M Sell
9,846
-1,802
-15% -$335K 0.15% 67
2025
Q1 		$2.44M Buy
11,648
+134
+1% +$26.1K 0.22% 46
2024
Q4 		$2.05M Sell
11,514
-16
-0.1% -$2.94K 0.18% 54
2024
Q3 		$2.28M Buy
11,530
+3
+0% +$560 0.2% 51
2024
Q2 		$1.98M Buy
+11,527
New +$1.91M 0.2% 50

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hardy Reed's ABBV Position: Q2 2026 in Review

Hardy Reed reduced its AbbVie (ABBV) stake by 3% in Q2 2026, selling an estimated $63.7K and leaving 9,616 shares worth $2.42M. The position accounts for 0.16% of the portfolio, ranked #61.

Hardy Reed first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.44M in Q1 2025. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hardy Reed held 9,616 shares of AbbVie worth $2.42M as of Q2 2026.
  • Hardy Reed sold 296 AbbVie shares in Q2 2026, an estimated $63.7K.
  • AbbVie made up 0.16% of Hardy Reed's portfolio in Q2 2026, its #61 holding.
  • Hardy Reed first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • Hardy Reed's AbbVie position peaked at $2.44M in Q1 2025.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hardy Reed's 13F filing for Q2 2026, filed 3 Aug 2026.